<?xml version="1.0" encoding="UTF-8"?>
<p>New effective drugs targeting the polymerase would be a promising strategy against IAV infection, since they would directly reduce or eliminate viral replication. Numerous sites, including the cap-binding site [
 <xref rid="B228-viruses-12-00376" ref-type="bibr">228</xref>], the endonuclease [
 <xref rid="B229-viruses-12-00376" ref-type="bibr">229</xref>,
 <xref rid="B230-viruses-12-00376" ref-type="bibr">230</xref>], and PA-PB1 inter-subunit interface [
 <xref rid="B231-viruses-12-00376" ref-type="bibr">231</xref>] can serve as potential targeting sites for new drug design. Coumarin compounds, including Eleutheroside B
 <sub>1</sub>, Isofraxidin, Fraxin, Esculetin, Fraxetin, and Scoparone, were investigated for their antiviral and anti-inflammatory activities against influenza virus in vitro [
 <xref rid="B31-viruses-12-00376" ref-type="bibr">31</xref>].
</p>
